| scholarly article | Q13442814 |
| P2093 | author name string | Marie-Pier Tétreault | |
| P2860 | cites work | Recent developments in esophageal adenocarcinoma | Q26849652 |
| Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model | Q27321510 | ||
| Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers | Q28545204 | ||
| Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium | Q28593684 | ||
| One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering | Q29547524 | ||
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas | Q30491937 | ||
| Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins | Q30650458 | ||
| Lineage commitment and maturation of epithelial cells in the gut. | Q33541264 | ||
| Antineoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice. | Q54641403 | ||
| Esophageal Cancer | Q56209683 | ||
| Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several? | Q63547602 | ||
| Amplification and expression of the human cyclin D gene in esophageal cancer | Q68055776 | ||
| The galvanization of biology: a growing appreciation for the roles of zinc | Q70995740 | ||
| Carcinogenesis by methylbenzylnitrosamine near the squamocolumnar junction and methylamylnitrosamine metabolism in the mouse forestomach | Q71005997 | ||
| Heterotransplantation of human esophageal carcinoma to nude mice | Q71018612 | ||
| Human cyclin D1 oncogene and esophageal squamous cell carcinoma | Q71067258 | ||
| Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma | Q71079523 | ||
| Ultrastructural features of carcinomas induced in nude mice by the inoculation of human oesophageal carcinoma cell lines | Q71232465 | ||
| Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas | Q74027601 | ||
| A new in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma | Q74628289 | ||
| Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen | Q77643885 | ||
| Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium | Q77931470 | ||
| Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction | Q81364447 | ||
| Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis | Q85727467 | ||
| Esophageal carcinoma | Q86401144 | ||
| Barrett's esophagus | Q87672139 | ||
| Development and characterization of a surgical mouse model of reflux esophagitis and Barrett's esophagus | Q42447910 | ||
| Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. | Q42471910 | ||
| Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice | Q42473769 | ||
| p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. | Q42495874 | ||
| Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk | Q43650533 | ||
| p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. | Q44272064 | ||
| Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis | Q44521116 | ||
| Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment | Q44944972 | ||
| Eosinophil depletion protects mice from tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. | Q45938382 | ||
| A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion | Q46900945 | ||
| Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. | Q51912557 | ||
| Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. | Q52078915 | ||
| Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. | Q53538850 | ||
| p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. | Q53617705 | ||
| Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. | Q53945793 | ||
| [Tumorinduction in mice with methylbenzylnitrosamine in low doses]. | Q53959592 | ||
| Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities | Q33612658 | ||
| History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus | Q33786336 | ||
| Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide | Q33789889 | ||
| Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic | Q33888212 | ||
| Frequent mutation of the p53 gene in human esophageal cancer | Q33927516 | ||
| Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice | Q34135989 | ||
| Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature | Q34241444 | ||
| Oesophageal carcinoma | Q34325751 | ||
| Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses | Q34389503 | ||
| Identification of genomic alterations in oesophageal squamous cell cancer | Q34412178 | ||
| Genetic landscape of esophageal squamous cell carcinoma | Q34434773 | ||
| Animal models of stomach carcinogenesis | Q34581372 | ||
| Stem cells of the oesophageal epithelium | Q34603090 | ||
| A mouse model of human oral-esophageal cancer | Q34796816 | ||
| Residual embryonic cells as precursors of a Barrett's-like metaplasia. | Q35073657 | ||
| Genetic Alterations in Esophageal Cancer | Q35113191 | ||
| Human cancer growth and therapy in immunodeficient mouse models | Q35545282 | ||
| The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin | Q35555290 | ||
| Inflammatory gradient in Barrett's oesophagus: implications for disease complications | Q35594952 | ||
| Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus | Q35692414 | ||
| Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages | Q35761435 | ||
| Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus | Q35953908 | ||
| Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer | Q36004154 | ||
| Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer. | Q36121407 | ||
| Different keratin polypeptides in epidermis and other epithelia of human skin: a specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas | Q36206936 | ||
| Functional differences between keratins of stratified and simple epithelia | Q36255586 | ||
| New orthotopic implantation model of human esophageal squamous cell carcinoma in athymic nude mice | Q36439545 | ||
| Barrett esophagus: what a mouse model can teach us about human disease | Q36556299 | ||
| Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer | Q36567970 | ||
| Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials | Q36622291 | ||
| p53 alterations in human cancer: more questions than answers. | Q36777320 | ||
| Basal cells as stem cells of the mouse trachea and human airway epithelium | Q37271261 | ||
| Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium | Q37329252 | ||
| Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients | Q37362098 | ||
| How does inflammation cause Barrett's metaplasia? | Q37614671 | ||
| One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering | Q37651840 | ||
| Epidemiology of gastrointestinal and liver tumors. | Q37760164 | ||
| Mouse models of cancer | Q37799368 | ||
| Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia | Q37880176 | ||
| Epidemiologic risk factors for esophageal cancer development | Q37982813 | ||
| Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer | Q38032432 | ||
| The sox family of transcription factors: versatile regulators of stem and progenitor cell fate | Q38071714 | ||
| Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery | Q38118539 | ||
| The esophagitis to adenocarcinoma sequence; the role of inflammation | Q38133153 | ||
| Krüppel-like factors in cancer | Q38141516 | ||
| Cancer cell lines for drug discovery and development | Q38203358 | ||
| Lessons from patient-derived xenografts for better in vitro modeling of human cancer | Q38259113 | ||
| Tcf3 governs stem cell features and represses cell fate determination in skin | Q38308903 | ||
| SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma | Q38340534 | ||
| Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice | Q38480535 | ||
| Visualizing gene expression in living mammals using a bioluminescent reporter. | Q38555717 | ||
| Animal Species in which N-nitroso compounds induce cancer | Q38577320 | ||
| Esophageal cancer and microelements | Q38619711 | ||
| K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression | Q38969680 | ||
| Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer | Q39250772 | ||
| Orthotopic models of esophageal carcinoma and their use in drug discovery | Q39478437 | ||
| Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene | Q39560761 | ||
| Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma | Q39683755 | ||
| Interactions of 4-nitroquinoline 1-oxide with deoxyribodinucleotides | Q39687362 | ||
| Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases | Q39729499 | ||
| The establishment of a new mouse model with orthotopic esophageal cancer showing the esophageal stricture. | Q39740106 | ||
| Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model | Q39784658 | ||
| Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo | Q39848176 | ||
| Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus | Q39853174 | ||
| Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway | Q39915434 | ||
| Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. | Q40274206 | ||
| Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus | Q40417530 | ||
| Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. | Q40671403 | ||
| Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion | Q40870166 | ||
| Vitamin E protection against nitrosamine-induced esophageal tumor incidence in mice immunocompromised by retroviral infection | Q41086379 | ||
| Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells | Q41260832 | ||
| A versatile orthotopic nude mouse model for study of esophageal squamous cell carcinoma. | Q42180656 | ||
| The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach | Q42437421 | ||
| P433 | issue | Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal cancer | Q372701 |
| P304 | page(s) | 37-46 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Cancer growth and metastasis | Q27722549 |
| P1476 | title | Esophageal Cancer: Insights From Mouse Models | |
| P478 | volume | 8 |
| Q36287407 | A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma |
| Q36365016 | ANIMAL MODELS OF CANCER BIOLOGY. |
| Q38664413 | Chemotherapy Induces Oral Mucositis in Mice Without Additional Noxious Stimuli |
| Q38683830 | Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection. |
| Q26772947 | Inherited PTEN mutations and the prediction of phenotype |
| Q28069480 | Laboratory animal models for esophageal cancer |
| Q48502077 | Oesophageal Stem Cells and Cancer. |
| Q48116418 | Topical protection of mice laryngeal mucosa using the natural product cashew gum. |
| Q42119412 | Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. |
Search more.